VR Logo

Balaxi Pharmaceuticals Ltd. download report


Services | Trading

Balaxi Pharmaceuticals Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Balaxi Pharmaceuticals Ltd. director's report Balaxi Pharmaceuticals Ltd. management discussion Balaxi Pharmaceuticals Ltd. corporate governance Balaxi Pharmaceuticals Ltd. auditor's report Balaxi Pharmaceuticals Ltd. account notes
2020 Balaxi Pharmaceuticals Ltd. Annual Report Balaxi Pharmaceuticals Ltd. chairman speech Balaxi Pharmaceuticals Ltd. director's report Balaxi Pharmaceuticals Ltd. management discussion Balaxi Pharmaceuticals Ltd. corporate governance Balaxi Pharmaceuticals Ltd. auditor's report Balaxi Pharmaceuticals Ltd. account notes
2019 Balaxi Pharmaceuticals Ltd. Annual Report Balaxi Pharmaceuticals Ltd. chairman speech Balaxi Pharmaceuticals Ltd. director's report Balaxi Pharmaceuticals Ltd. management discussion Balaxi Pharmaceuticals Ltd. corporate governance Balaxi Pharmaceuticals Ltd. auditor's report Balaxi Pharmaceuticals Ltd. account notes
2018 Balaxi Pharmaceuticals Ltd. Annual Report Balaxi Pharmaceuticals Ltd. chairman speech Balaxi Pharmaceuticals Ltd. director's report Balaxi Pharmaceuticals Ltd. management discussion Balaxi Pharmaceuticals Ltd. corporate governance Balaxi Pharmaceuticals Ltd. auditor's report Balaxi Pharmaceuticals Ltd. account notes
2017 Balaxi Pharmaceuticals Ltd. Annual Report Balaxi Pharmaceuticals Ltd. chairman speech Balaxi Pharmaceuticals Ltd. director's report Balaxi Pharmaceuticals Ltd. management discussion Balaxi Pharmaceuticals Ltd. corporate governance Balaxi Pharmaceuticals Ltd. auditor's report Balaxi Pharmaceuticals Ltd. account notes
2016 Balaxi Pharmaceuticals Ltd. Annual Report Balaxi Pharmaceuticals Ltd. chairman speech Balaxi Pharmaceuticals Ltd. director's report Balaxi Pharmaceuticals Ltd. management discussion Balaxi Pharmaceuticals Ltd. corporate governance Balaxi Pharmaceuticals Ltd. auditor's report Balaxi Pharmaceuticals Ltd. account notes

About The Company

Business: Financial service activities, except insurance and pension funding

Incorporated: 1942

Chairman: --

Managing Director: Ashish Maheshwari

Listing: NSE: BALAXI

Country: India

Headquarters: Hyderabad, Telangana

Website: www.balaxipharma.in

Key Facts

Market cap: ₹369.95 Cr

Revenue (TTM): ₹279.39 Cr

Earnings (TTM): ₹47.66 Cr

Cash: ₹7.19 Cr

Total Debt: ₹3.64 Cr

Promoters' ownership: 72.86%

Liquidity: Low

52 Week range: ₹303.55 - 700.00

Face value: ₹10.00

Shares outstanding: 1,00,00,000

10 Years Aggregate:

  • CFO: ₹18.06 Cr
  • EBITDA: ₹102.50 Cr
  • Net Profit: ₹93.10 Cr

Stock Performance

Time Period Balaxi Pharmaceuticals S&P BSE CDG&S S&P BSE Small Cap
YTD-27.90-10.47-15.25
1 month-9.890.19-2.56
3 months-6.92-4.37-10.20
1 Year-37.002.45-0.12
3 Years65.3113.2020.55
5 Years--7.2310.52
10 Years----14.50
As on 28-Jun-2022
Year Balaxi Pharmaceuticals S&P BSE Small Cap S&P BSE CDG&S
2021-19.9762.7729.72
2020725.7932.1120.33